觀察使用睫狀肌麻痺劑與角膜塑型鏡學童近視進展,並且探討使用睫狀肌麻痺劑與角膜塑型鏡學童控制近視成效。 本研究時間為期一年,受試者共41位,角膜塑型鏡組20人,睫狀肌麻痺劑組21人,年齡層7~15歲,平均年齡10歲,近視度數小於 -4.50D,散光度數小於-1.50D,觀察球面度數、散光度數、等價球面度數、軸長長度、視力值數據追蹤。 研究結果顯示睫狀肌麻痺劑組一年屈光度在球面度數分別為-1.71±0.77D,散光度數為-0.67±0.88D,等價球面度數分別為-0.67±0.88D,睫狀肌麻痺劑組合角膜塑型鏡組軸長分別為24.68±0.75mm、24.67±0.55mm,睫狀肌麻痺劑組近視度數一年改變量-0.18±0.61D,前六個月軸長改變量+0.08±0.15 mm,後六個月軸長改變量+0.15±0.31mm,角膜塑型鏡組前六個月軸長改變量+0.05±0.83 mm,後六個月軸長改變量+0.13±0.15mm。 本研究結論睫狀肌麻痺劑與角膜塑型鏡是有控制近視效果,兩組眼軸長的變化是以配戴角膜塑型鏡組在一年時間改變量較少。
Title of presentation The effectiveness of atropine and orthokeratology (OK) lens for myopic control in Taiwan. Purpose This study aimed to investigate relationship between changes in the progression of myopia and axial length with atropine and orthokeratology. Method Forty-one children aged 7-15 year old and determining the modality of the patient’s parents. This is a clinical study for one year period. Myopic children with good ocular conditions were fitted OK lens and using atropine (concentration 0.3%) for one year period. The mean values for objective and subjective refractive error, visual acuity, and axial length were measure at baseline and every 3 month. Results Comparison of increases in axial length in relation to myopia showed that correlations in both groups. Twenty-one subjects had used atropine for one year period. In the atropine groups, the change in the myopia was -0.22±0.56 D and the axial length increased in the past six month by 0.08±0.15 mm, and the next six month by 0.15±0.31 mm. In the OK groups, the change in the myopia was +1.31±1.43D and the axial length increased the past six month by 0.05±0.83 mm, and the next six month by 0.13±0.15 mm. Conclusion The result showed that atropine and OK are effective in controlling myopia progression in low-moderate myopic children for one year period observation. The evidence was shows that OK was effective for slow eye elongation in Taiwan children